Dr. Douglas is a Senior Partner Emeritus at PureTech Ventures. He is President and CEO of Austen BioInnovation Institute in Akron, Ohio, a best-in-class model for the future of health care delivery and innovation. Previously, he was Professor of the Practice at MIT, the Harvard-MIT Division of Health Sciences & Technology, and Executive Director of the MIT Center for Biomedical Innovation.
Dr. Douglas was also a member of the Board of Management and Executive Vice President, Drug Innovation and Approval, and Chief Scientific Officer of Aventis SA, where he oversaw global pharmaceutical research, development and regulatory activities. Prior to his positions with Aventis, Dr. Douglas was EVP of Global Research at Hoechst Marion Roussel, EVP of Research and Development at Marion Merrel Dow, and SVP & Director of Research at CIBA-GEIGY.
He also served as Chairman of the Executive Committee of the Science and Regulatory Section of the Pharmaceutical Research and Manufacturers Association (PhRMA), has been a member of the Scientific Advisory Board of the U.S. Food and Drug Administration, the Advisory Board of the Paul Ehrlich Foundation, and a member of the Board of Directors of Alantos, Gene Logic, Nitromed Inc., and Archemix Inc. Currently, Dr. Douglas is President and CEO of the Bioinnovation Institute in Akron, and a Kauffman Foundation Senior Fellow. He has received the Lewis B. Russell Memorial Award from the American Heart Association, the J.W. von Goethe Frankfurt University Medal of Honor and was named the recipient of the Global Pharmaceutical R&D Director of the Year Award in 2001, and again in 2004.
Throughout his career Dr. Douglas has led teams that have discovered, developed, or extended the indications of more than 20 drugs. As a senior executive, he pioneered organizational changes that were forerunners in the emerging field of Translational Medicine, and he introduced Chemical Biology Platforms to the pharmaceutical industry. Dr. Douglas received his PhD in physical chemistry and MD from Cornell University.